SE8303211D0 - Rena teichomycin a?712 singelfaktorer 1,2,3,4 och 5 och sett for deras framstellning - Google Patents

Rena teichomycin a?712 singelfaktorer 1,2,3,4 och 5 och sett for deras framstellning

Info

Publication number
SE8303211D0
SE8303211D0 SE8303211A SE8303211A SE8303211D0 SE 8303211 D0 SE8303211 D0 SE 8303211D0 SE 8303211 A SE8303211 A SE 8303211A SE 8303211 A SE8303211 A SE 8303211A SE 8303211 D0 SE8303211 D0 SE 8303211D0
Authority
SE
Sweden
Prior art keywords
teichomycin
factor
rena
sets
preparation
Prior art date
Application number
SE8303211A
Other languages
English (en)
Other versions
SE459094B (sv
SE8303211L (sv
Inventor
A Borghi
R Pallanza
C Coronelli
G Cassani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE8303211D0 publication Critical patent/SE8303211D0/sv
Publication of SE8303211L publication Critical patent/SE8303211L/sv
Publication of SE459094B publication Critical patent/SE459094B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8303211A 1982-06-08 1983-06-07 Rena teichomycin a2 singelfaktorer 1, 2, 3, 4 och 5 samt saett foer deras framstaellning samt antibiotisk och farmaceutisk komposition innehaallande desamma SE459094B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (3)

Publication Number Publication Date
SE8303211D0 true SE8303211D0 (sv) 1983-06-07
SE8303211L SE8303211L (sv) 1983-12-09
SE459094B SE459094B (sv) 1989-06-05

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303211A SE459094B (sv) 1982-06-08 1983-06-07 Rena teichomycin a2 singelfaktorer 1, 2, 3, 4 och 5 samt saett foer deras framstaellning samt antibiotisk och farmaceutisk komposition innehaallande desamma

Country Status (32)

Country Link
US (1) US4542018A (sv)
JP (5) JPS591423A (sv)
KR (1) KR900008246B1 (sv)
AU (1) AU560966B2 (sv)
BE (1) BE896993A (sv)
BG (1) BG60529B2 (sv)
CA (1) CA1208204A (sv)
CH (1) CH657139A5 (sv)
DE (1) DE3320342A1 (sv)
DK (1) DK159117C (sv)
ES (2) ES522941A0 (sv)
FI (1) FI73697C (sv)
FR (1) FR2528050B1 (sv)
GB (1) GB2121401B (sv)
GR (1) GR78267B (sv)
HK (1) HK55887A (sv)
HU (1) HU193538B (sv)
IE (1) IE55025B1 (sv)
IL (1) IL68819A0 (sv)
IT (1) IT1212085B (sv)
LU (1) LU84853A1 (sv)
MY (1) MY8700002A (sv)
NL (1) NL8301980A (sv)
NO (1) NO159104C (sv)
NZ (1) NZ204480A (sv)
PH (1) PH19533A (sv)
PT (1) PT76831B (sv)
SE (1) SE459094B (sv)
SG (1) SG70686G (sv)
SU (1) SU1318170A3 (sv)
UA (1) UA6025A1 (sv)
ZA (1) ZA833607B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
MXPA05005338A (es) 2002-11-18 2005-12-14 Vicuron Pharm Inc Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IT8321432A0 (it) 1983-06-02
JPH02291278A (ja) 1990-12-03
PT76831B (en) 1986-04-09
GR78267B (sv) 1984-09-26
SE459094B (sv) 1989-06-05
CH657139A5 (fr) 1986-08-15
FR2528050A1 (fr) 1983-12-09
DK245883A (da) 1983-12-09
JPH02288888A (ja) 1990-11-28
FI831660A0 (fi) 1983-05-12
FI73697C (sv) 1987-11-09
DE3320342A1 (de) 1983-12-08
SE8303211L (sv) 1983-12-09
IE831329L (en) 1983-12-08
PT76831A (en) 1983-07-01
BG60529B2 (bg) 1995-07-28
FI73697B (fi) 1987-07-31
ES8503689A1 (es) 1985-04-01
JPH02288887A (ja) 1990-11-28
UA6025A1 (uk) 1994-12-29
DK159117B (da) 1990-09-03
KR900008246B1 (ko) 1990-11-06
KR840005170A (ko) 1984-11-05
PH19533A (en) 1986-05-20
JPH0415238B2 (sv) 1992-03-17
JPH0415237B2 (sv) 1992-03-17
IL68819A0 (en) 1983-09-30
US4542018A (en) 1985-09-17
AU560966B2 (en) 1987-04-30
FI831660L (fi) 1983-12-09
DE3320342C2 (sv) 1991-07-11
NZ204480A (en) 1986-04-11
LU84853A1 (fr) 1984-03-07
HK55887A (en) 1987-08-07
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
JPH02291279A (ja) 1990-12-03
NL8301980A (nl) 1984-01-02
NO159104C (no) 1988-11-30
ES8506748A1 (es) 1985-08-16
CA1208204A (en) 1986-07-22
ES536770A0 (es) 1985-08-16
JPH0517236B2 (sv) 1993-03-08
SG70686G (en) 1987-07-03
NO159104B (no) 1988-08-22
DK245883D0 (da) 1983-05-31
AU1496883A (en) 1983-12-15
GB2121401B (en) 1985-09-18
JPS591423A (ja) 1984-01-06
HU193538B (en) 1987-10-28
FR2528050B1 (fr) 1987-03-20
JPH0224278B2 (sv) 1990-05-29
GB8315003D0 (en) 1983-07-06
GB2121401A (en) 1983-12-21
NO831754L (no) 1983-12-09
MY8700002A (en) 1987-12-31
ZA833607B (en) 1984-03-28
JPH0517237B2 (sv) 1993-03-08
SU1318170A3 (ru) 1987-06-15
ES522941A0 (es) 1985-04-01
DK159117C (da) 1991-02-11
BE896993A (fr) 1983-12-07

Similar Documents

Publication Publication Date Title
SE8303211D0 (sv) Rena teichomycin a?712 singelfaktorer 1,2,3,4 och 5 och sett for deras framstellning
IT8347779A0 (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
BE892270A (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
FI852522A0 (sv) Förfarande för framställning av tymopentinanaloger
FR2497207B1 (fr) Composition antigingivite, son procede de preparation et son application
DK232483D0 (da) Fremgangsmade til fremstilling af ws 6049-forbindelser
MA19331A1 (fr) Derives de la thieno - pyridinone , leur procede de preparation et leur application therapeutique .
NL192740B (nl) Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
DE3781878D1 (de) Antibiotikum-a10255-komplex und faktoren, verfahren, mikroorganismen fuer seine herstellung.
DE3372214D1 (en) Process for producing vitamin b12 by the fermentation technique, and vitamin b12-producing microorganism
KR950700684A (ko) 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use)
DE3376649D1 (en) Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions
FR2546180B1 (fr) Procede d'augmentation de la production d'antibiotique par recombinaison genetique in vivo
ITMI912149A0 (it) Procedimento per produrre l-lisina mediante fermentazione
FR2526798B1 (fr) Derives de peneme, leur procede de preparation et compositions therapeutiques les contenant
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
IT1176405B (it) Procedimento per produrre l-amminoacidi da alfa-chetoacidi mediante fermentazione
FR2540116B1 (fr) Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique
HUT58194A (en) Method for producing foodstuff-preparations suitable for introducing biologically important micro- and macro-elements
FR2477142B1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et leur application en therapeutique
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
DK0454494T3 (da) Calicheamicinoner, derivater deraf og analoge dertil og fremgangsmåde til fremstilling af disse
ITMI912873A0 (it) Procedimento per produrre l-lisina mediante fermentazione
FR2534255B1 (fr) Nouveaux derives de la 4-aroylamino piperidine, leur procede de preparation et leur application en therapeutique
FI883442A0 (fi) Strumpartad naetanordning, saett foer framstaellning av anordningen och apparat foer utfoerande av saettet.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8303211-0

Format of ref document f/p: F

NUG Patent has lapsed